文献速递头颈部肿瘤放疗放疗物理与技术

GIRAFE II期试验:基于MVCT的「当日体积」与「当日剂量」探讨局部晚期头颈癌自适应放疗的实施时机与方法

The GIRAFE phase II trial on MVCT-based "volumes of the day" and "dose of the day" addresses when and how to implement adaptive radiotherapy for locally advanced head and neck cancer.
PubMed 文献 · Clin Transl Radiat Oncol · 2019-03-09

GIRAFE II期前瞻性研究拟纳入48例T3-T4和/或淋巴结>2 cm的头颈鳞癌患者,根治性 helical IMRT 期间每周行MVCT,于第3、4、5、6周中间计划CT上比较自动形变轮廓与手动重勾画,主要终点为双侧腮腺体积的Dice相似系数,并比较自动与手动重计划流程耗时。

要点

  • 拟纳入48例T3-T4和/或受累淋巴结>2 cm、接受根治性放疗的头颈鳞癌患者。
  • 治疗采用 helical IMRT 并每日MVCT复位,第3、4、5、6周行中间计划CT比较轮廓。
  • 主要终点为双侧腮腺体积的Dice相似系数,次要终点包括靶区与所有OAR的DSC、平均一致距离和平均表面距离。

核心结论

  • 研究设计旨在验证每日MVCT上自动形变轮廓的有效性,以安全使用「当日剂量」工具每日判断是否需要重计划。
  • 同时评估重计划CT上自动形变轮廓及重计划流程节省的时间。

研究设计与样本

  • 前瞻性研究,拟纳入48例T3-T4和/或受累淋巴结>2 cm、计划行根治性放疗且未手术的头颈鳞状细胞癌患者。
  • 患者接受 helical IMRT 治疗,包括每日复位MVCT。

主要发现

  • 原文为研究方案,尚未报告主要终点结果。

关键数值与推荐

  • 主要目标为评估双侧腮腺各体积的Dice相似系数。
  • 次要目标针对靶区和所有OAR评估DSC、平均一致距离和平均表面距离。
  • 比较自动与手动重勾画流程之间的时间。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

During exclusive curative radiotherapy for head and neck tumors, the patient's organs at risk (OAR) and target volumes frequently change size and shape, leading to a risk of higher toxicity and lower control than expected on planned dosimetry. Adaptive radiotherapy is often necessary but 1) tools are needed to define the optimal time for replanning, and 2) the subsequent workflow is time-consuming. We designed a prospective study to evaluate 1) the validity of automatically deformed contours on the daily MVCT, in order to safely use the "dose-of the day" tool to check daily if replanning is necessary; 2) the automatically deformed contours on the replanning CT and the time gained in the replanning workflow. Forty-eight patients with T3-T4 and/or involved node >2 cm head and neck squamous cell carcinomas, planned for curative radiotherapy without surgery, will be enrolled. They will undergo treatment with helical IMRT including daily repositioning MVCTs. The contours proposed will be compared weekly on intermediate planning CTs (iCTs) on weeks 3, 4, 5 and 6. On these iCTs both manual recontouring and automated deformable registration of the initial contours will be compared with the contours automatically defined on the MVCT. The primary objective is to evaluate the Dice similarity coefficient (DSC) of the volumes of each parotid gland. The secondary objectives will evaluate, for target volumes and all OARs: the DSC, the mean distance to agreement, and the average surface-to-surface distance. Time between the automatic and the manual recontouring workflows will be compared.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Esteyrie V, Gleyzolle B, Lusque A, et al. The GIRAFE phase II trial on MVCT-based "volumes of the day" and "dose of the day" addresses when and how to implement adaptive radiotherapy for locally advanced head and neck cancer. Clin Transl Radiat Oncol. 2019. PMID: 30949592. doi:10.1016/j.ctro.2019.02.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。